Abstract: An athletic shoe suitable for efficient running. A depression is formed in the rear foot portion which extends forward from the calcaneal bone and which does not contact the ground. A band-like area is provided in the middle foot portion extending in the front-rear direction in the central portion between the medial side and the lateral side of the shoe sole so as to be continuous with the depression. The reinforcement member and the midsole are provided in the middle foot portion so that the upper surface of the midsole less easily sinks downward due to a load from above on the medial side than in the band-like area and on the lateral side. In the front foot portion, a longitudinal groove is formed which extends in the front-rear direction in the central portion of the midsole body so as to be continuous with the band-like area. The longitudinal groove is curved so as to be generally parallel to the lateral edge of the front foot portion of sole.

Abstract: A heel counter 4 includes: a support section 43 extending in a forward direction from a back side 1b of an upper 1; a rib 40 extending in the forward direction generally in parallel to the support section 43 at a position above the support section 43 from the back side 1b of the upper 1 along a medial side 11 and extending in the forward direction generally in parallel to the support section 43 at a position above the support section 43 from the back side 1b of the upper 1 along a lateral side 12; and first and second bridge means 41a, 41b and 42 connecting the support section 43 and the rib 40 to each other allowing the support section 43 to support the rib 40, wherein: a foremost one 46b of a plurality of connection portions 46b, 46c and 46e by which the rib 40 and the bridge means 41a, 41b and 42 are connected to each other is provided on the medial side of the upper 1; and the foremost connection portion 46b is located forward of a rear end of a talus bone B8.

Abstract: The object of the present invention is to provide an oral cavity composition which is nontoxic, excellent in plaque control, can prevent or treat onset of caries and periodontal disease caused by oral pathogens as well as can prevent or eliminate bad breath. The invention provides an oral cavity composition containing a lactic acid bacterium, Streptococcus faecalis as an active ingredient, the oral cavity composition wherein the lactic acid bacterium, Streptococcus faecalis is Streptococcus faecalis WB2000 strain and the oral cavity composition which is a non-aqueous oral cavity composition.

Abstract: The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids, a composition for preventing and/or treating digestive tract's diseases comprising the probiotics product as an effective component and a novel Lactobacillus salivarius strain possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids. The lactic acid bacteria and the probiotics product and the composition for preventing and/or treating digestive tract's diseases, which contain the lactic acid bacteria as an effective component, according to the present invention can sufficiently show their probiotics functions without being easily discharged from the digestive tract and urinogenital organs.

Abstract: The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids, a composition for preventing and/or treating digestive tract's diseases comprising the probiotics product as an effective component and a novel Lactobacillus salivarius strain possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids. The lactic acid bacteria and the probiotics product and the composition for preventing and/or treating digestive tract's diseases, which contain the lactic acid bacteria as an effective component, according to the present invention can sufficiently show their probiotics functions without being easily discharged from the digestive tract and urinogenital organs.

Abstract: Antibiotics WAP-8294A, A.sub.1, A.sub.2, A.sub.4, AX, AX-8, AX-9 and AX-13 or pharmeceutically acceptable salts thereof produced by a strain belonging to the genus Lysobacter; a method for producing the foregoing antibiotic WAP-8294A comprising the steps of cultivating, in the culture medium, a microorganism belonging to the genus Lysobacter and having an ability of producing the antibiotic WAP-8294A to produce the antibiotic and accumulate it in the culture medium; then recovering the antibiotic; as well as an antibacterial composition comprising the antibiotic or pharmaceutically acceptable salts thereof are herein disclosed. The novel antibiotic WAP-8294A has an excellent therapeutic effect on infectious diseases developed by infection with Gram-positive bacteria, in particular, MRSA and, therefore, the antibiotic is effective for treating diseases including MRSA infectious diseases developed through infection with Gram-positive bacteria as infectious bacteria.